ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,357,000 | -11.7% | 50,000 | 0.0% | 0.05% | -9.6% |
| Q2 2023 | $1,537,000 | -14.7% | 50,000 | 0.0% | 0.05% | -30.7% |
| Q1 2023 | $1,801,500 | -8.8% | 50,000 | 0.0% | 0.08% | -22.7% |
| Q4 2022 | $1,976,000 | -99.9% | 50,000 | -19.0% | 0.10% | -20.5% |
| Q3 2022 | $2,480,994,000 | +95469.9% | 61,747 | 0.0% | 0.12% | +1.7% |
| Q2 2022 | $2,596,000 | +7.9% | 61,747 | 0.0% | 0.12% | +30.4% |
| Q1 2022 | $2,406,000 | -2.2% | 61,747 | 0.0% | 0.09% | +9.5% |
| Q4 2021 | $2,461,000 | +10.3% | 61,747 | 0.0% | 0.08% | +1.2% |
| Q3 2021 | $2,232,000 | – | 61,747 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |